Justin P. Annes M.D., Ph.D.

Publication Details

  • Genetics of adrenocortical disease: an update CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY Bar-Lev, A., Annes, J. P. 2012; 19 (3): 159-167


    Disease states characterized by abnormal cellular function or proliferation frequently reflect aberrant genetic information. By revealing disease-specific DNA mutations, we gain insight into normal physiology, pathophysiology, potential therapeutic targets and are better equipped to evaluate an individual's disease risks. This review examines recent advances in our understanding of the genetic basis of adrenal cortical disease.Important advances made in the past year have included identification of KCNJ5 potassium channel mutations in the pathogenesis of both aldosterone-producing adenomas and familial hyperaldosteronism type III; characterization of phosphodiesterase 11A as a modifier of phenotype in Carney complex caused by protein kinase, cAMP-dependent, regulatory subunit, type-I mutations; the finding of 11?-hydroxysteroid dehydrogenase type I mutations as a novel mechanism for cortisone reductase deficiency; and demonstration of potential mortality benefit in pursuing comprehensive presymptomatic screening for patients with Li-Fraumeni syndrome, including possible reduction in risks associated with adrenocortical carcinoma.This research review provides a framework for the endocrinologist to maintain an up-to-date understanding of adrenal cortical disease genetics.

    View details for DOI 10.1097/MED.0b013e328352f013

    View details for Web of Science ID 000303255900003

    View details for PubMedID 22476103

Stanford Medicine Resources:

Footer Links: